Asthma Treatment Global Market Report 2025

Description

Asthma treatment involves the medical approaches and management techniques aimed at controlling and alleviating asthma symptoms, preventing attacks, and enhancing lung function in affected individuals. This treatment focuses on reducing airway inflammation and managing symptoms to improve breathing.

The primary categories of asthma treatment include long-term control medications and quick-relief medications. Long-term control medications are taken daily to maintain asthma control and prevent symptoms. Devices used for administering these treatments include inhalers, dry powder inhalers, metered-dose inhalers, and soft mist nebulizers. Drug classes involved are short-acting beta-agonists (SABA), long-acting beta-agonists (LABA), inhaled corticosteroids (ICS), leukotriene modifiers, immunomodulators, combination drugs, and others. Administration routes encompass oral, inhaled, intravenous, and subcutaneous methods. These medications are distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The asthma treatment market research report is one of a series of new reports from The Business Research Company that provides asthma treatment market statistics, including asthma treatment industry global market size, regional shares, competitors with an asthma treatment market share, asthma treatment market segments, market trends and opportunities, and any further data you may need to thrive in the asthma treatment industry. This asthma treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The asthma treatment market size has grown steadily in recent years. It will grow from $22.69 billion in 2024 to $23.75 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth during the historic period can be attributed to rising urbanization and pollution levels, increased use of inhalers and nebulizers, improved healthcare access in emerging markets, heightened awareness and diagnosis rates, and greater exposure to allergens.

The asthma treatment market size is expected to see steady growth in the next few years. It will grow to $28.27 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The anticipated growth in the forecast period can be linked to an increasing emphasis on personalized asthma treatments, greater adoption of biologics and monoclonal antibodies, rising investments in respiratory drug research and development, expanded use of telehealth and digital asthma management tools, and enhanced government initiatives focused on chronic respiratory care. Key trends expected include progress in biologic therapies for severe asthma, development of advanced digital inhalers with tracking capabilities, innovations in personalized medicine, improvements in drug-delivery technologies, and advancements in AI-powered asthma management platforms.

The rising prevalence of respiratory disorders is expected to drive the growth of the asthma treatment market in the coming years. Respiratory disorders encompass diseases that affect the lungs and breathing, such as chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. This increase is largely linked to air pollution, as particulate matter and nitrogen oxides irritate and inflame the airways, causing breathing difficulties and worsening conditions like asthma. The growing number of respiratory disorder cases is boosting demand for asthma treatments, which include medications, inhalers, and lifestyle modifications to manage airway inflammation and symptoms. For example, in December 2023, the National Library of Medicine, a US-based institution, reported that by 2050, COPD cases in low- and middle-income countries are expected to more than double those in high-income countries, with sub-Saharan Africa projected to see a 59% rise and lead globally in COPD prevalence and cases by 2040. Thus, the increasing prevalence of respiratory disorders is fueling growth in the asthma treatment market.

Leading companies in the asthma treatment market are focusing on developing innovative products, such as anti-inflammatory rescue inhalers, to provide rapid symptom relief while simultaneously addressing airway inflammation in asthma patients. Anti-inflammatory rescue inhalers deliver quick relief during asthma attacks and reduce underlying airway inflammation. For instance, in January 2024, AstraZeneca, a UK-based biopharmaceutical firm, introduced AIRSUPRA (albuterol/budesonide), a novel inhaler for asthma. It is the first and only FDA-approved fixed-dose combination of albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS), designed specifically as a rescue medication for asthma. This inhaler provides fast bronchodilation and targets airway inflammation during exacerbations, treating both symptoms and inflammation with a single inhalation. It is intended for patients aged 18 and older and aims to improve overall asthma control while reducing dependence on separate controller medications.

In January 2024, GSK plc, a UK-based pharmaceutical company, acquired Aiolos Bio for an undisclosed amount. Through this acquisition, GSK intends to enhance its respiratory treatment portfolio and support long-term growth by combining Aiolos Bio's innovative therapies with its global presence to better serve patients worldwide. Aiolos Bio is a US-based clinical-stage biopharmaceutical company focused on asthma treatment.

Major players in the asthma treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Sumitomo Pharma Co Ltd., Chiesi Farmaceutici S.p.A., and Cipla Limited.

North America was the largest region in the asthma treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in asthma treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the asthma treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The asthma treatment market consists of revenues earned by entities by providing services such as diagnosis, medication administration, inhalation therapy, monitoring, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The asthma treatment market also includes sales of nebulizers, leukotriene modifiers, corticosteroids, and bronchodilators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Asthma Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on asthma treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for asthma treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The asthma treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment: Long-Term Control Medications; Quick-Relief Medications
2) By Device Type: Inhalers; Dry Powder; Metered Dose; Soft Mist Nebulizers
3) By Drug Class: Short-Acting Beta-Agonists (SABA); Long-Acting Beta-Agonists (LABA); Inhaled Corticosteroids (ICS); Leukotriene Modifiers; Immunomodulators; Combination Drugs; Other Drug Class
4) By Route Of Administration: Oral; Inhaled; Intravenous; Subcutaneous
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Subsegments:
1) By Long-Term Control Medications: Inhaled Corticosteroids (ICS); Long-Acting Beta-Agonists (LABA); Leukotriene Receptor Antagonists (LTRA); Long-Acting Muscarinic Antagonists (LAMA); Methylxanthines; Biologics
2) By Quick-Relief Medications: Short-Acting Beta-Agonists (SABA); Systemic Corticosteroids; Anticholinergics
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A.; AstraZeneca PLC; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Amgen Inc.; Boehringer Ingelheim International GmbH; Teva Pharmaceutical Industries Limited; Regeneron Pharmaceuticals Inc.; Sun Pharmaceutical Industries Limited; Genentech Inc.; Sumitomo Pharma Co Ltd.; Chiesi Farmaceutici S.p.A.; Cipla Limited.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r36932

1. Executive Summary

2. Asthma Treatment Market Characteristics

3. Asthma Treatment Market Trends And Strategies

4. Asthma Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Asthma Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Asthma Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Asthma Treatment Market Growth Rate Analysis
5.4. Global Asthma Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Asthma Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Asthma Treatment Total Addressable Market (TAM)

6. Asthma Treatment Market Segmentation

6.1. Global Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Long-Term Control Medications
Quick-Relief Medications
6.2. Global Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhalers
Dry Powder
Metered Dose
Soft Mist Nebulizers
6.3. Global Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Short-Acting Beta-Agonists (SABA)
Long-Acting Beta-Agonists (LABA)
Inhaled Corticosteroids (ICS)
Leukotriene Modifiers
Immunomodulators
Combination Drugs
Other Drug Class
6.4. Global Asthma Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Inhaled
Intravenous
Subcutaneous
6.5. Global Asthma Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.6. Global Asthma Treatment Market, Sub-Segmentation Of Long-Term Control Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhaled Corticosteroids (ICS)
Long-Acting Beta-Agonists (LABA)
Leukotriene Receptor Antagonists (LTRA)
Long-Acting Muscarinic Antagonists (LAMA)
Methylxanthines
Biologics
6.7. Global Asthma Treatment Market, Sub-Segmentation Of Quick-Relief Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Short-Acting Beta-Agonists (SABA)
Systemic Corticosteroids
Anticholinergics

7. Asthma Treatment Market Regional And Country Analysis

7.1. Global Asthma Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Asthma Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Asthma Treatment Market

8.1. Asia-Pacific Asthma Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Asthma Treatment Market

9.1. China Asthma Treatment Market Overview
9.2. China Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Asthma Treatment Market

10.1. India Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Asthma Treatment Market

11.1. Japan Asthma Treatment Market Overview
11.2. Japan Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Asthma Treatment Market

12.1. Australia Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Asthma Treatment Market

13.1. Indonesia Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Asthma Treatment Market

14.1. South Korea Asthma Treatment Market Overview
14.2. South Korea Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Asthma Treatment Market

15.1. Western Europe Asthma Treatment Market Overview
15.2. Western Europe Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Asthma Treatment Market

16.1. UK Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Asthma Treatment Market

17.1. Germany Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Asthma Treatment Market

18.1. France Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Asthma Treatment Market

19.1. Italy Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Asthma Treatment Market

20.1. Spain Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Asthma Treatment Market

21.1. Eastern Europe Asthma Treatment Market Overview
21.2. Eastern Europe Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Asthma Treatment Market

22.1. Russia Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Asthma Treatment Market

23.1. North America Asthma Treatment Market Overview
23.2. North America Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Asthma Treatment Market

24.1. USA Asthma Treatment Market Overview
24.2. USA Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Asthma Treatment Market

25.1. Canada Asthma Treatment Market Overview
25.2. Canada Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Asthma Treatment Market

26.1. South America Asthma Treatment Market Overview
26.2. South America Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Asthma Treatment Market

27.1. Brazil Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Asthma Treatment Market

28.1. Middle East Asthma Treatment Market Overview
28.2. Middle East Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Asthma Treatment Market

29.1. Africa Asthma Treatment Market Overview
29.2. Africa Asthma Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Asthma Treatment Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Asthma Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Asthma Treatment Market Competitive Landscape And Company Profiles

30.1. Asthma Treatment Market Competitive Landscape
30.2. Asthma Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Asthma Treatment Market Other Major And Innovative Companies

31.1. Bayer AG
31.2. Novartis AG
31.3. Sanofi S.A.
31.4. AstraZeneca PLC
31.5. GlaxoSmithKline plc
31.6. Takeda Pharmaceutical Company Limited
31.7. Amgen Inc.
31.8. Boehringer Ingelheim International GmbH
31.9. Teva Pharmaceutical Industries Limited
31.10. Regeneron Pharmaceuticals Inc.
31.11. Sun Pharmaceutical Industries Limited
31.12. Genentech Inc.
31.13. Sumitomo Pharma Co Ltd.
31.14. Chiesi Farmaceutici S.p.A.
31.15. Cipla Limited

32. Global Asthma Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Asthma Treatment Market

34. Recent Developments In The Asthma Treatment Market

35. Asthma Treatment Market High Potential Countries, Segments and Strategies

35.1 Asthma Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Asthma Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Asthma Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer